Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada

Journal of Thoracic Oncology

Volumn 9, Issue 10, 2014, Pages 1449-1458

  Cressman, Sonya ^a   Lam, Stephen ^a   Tammemagi, Martin C ^b   Evans, William K ^c   Leighl, Natasha B ^d   Regier, Dean A ^e   Bolbocean, Corneliu ^e   Shepherd, Frances A ^d   Tsao, Ming Sound ^d   Manos, Daria ^f   Liu, Geoffrey ^d   Atkar Khattra, Sukhinder ^a   Cromwell, Ian ^e   Johnston, Michael R ^g   Mayo, John R ^h   McWilliams, Annette ⁱ   Couture, Christian ^j   English, John C ^e   Goffin, John ^k   Hwang, David M ^d   Puksa, Serge ^k   Roberts, Heidi ^d   Tremblay, Alain ^l   MacEachern, Paul ^m   Burrowes, Paul ^m   Bhatia, Rick ⁿ   Finley, Richard J ^h   Goss, Glenwood D ^o   Nicholas, Garth ^p   Seely, Jean M ^o   Sekhon, Harmanjatinder S ^o   Frcsc, John Yee ^e   Amjadi, Kayvan ^o   Cutz, Jean Claude ^q   Ionescu, Diana N ^a   Yasufuku, Kazuhiro ^d   Martel, Simon ^r   Soghrati, Kamyar ^d   Sin, Don D ^s   Tan, Wan C ^s   Urbanski, Stefan ^t   Xu, Zhaolin ^f   Peacock, Stuart J ^e   more..

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BROCK UNIVERSITY   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h VANCOUVER GENERAL HOSPITAL   (Canada)

ⁱ FIONA STANLEY HOSPITAL   (Australia)

^j UNIVERSITÉ LAVAL   (Canada)

^k MCMASTER UNIVERSITY   (Canada)

^l UNIVERSITY OF CALGARY   (Canada)

^m FOOTHILLS HOSPITAL   (Canada)

ⁿ MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^o UNIVERSITY OF OTTAWA   (Canada)

^p OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^q MCMASTER UNIVERSITY   (Canada)

^r LAVAL UNIVERSITY   (Canada)

^s ST PAUL S HOSPITAL   (Canada)

^t Foothills Cancer Centre   (Canada)

more..

Author keywords

Cost analysis; Cost effectiveness; Lung cancer screening

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANADA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CANADA; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925870771     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000283     Document Type: Article

References (31)

1. Aberle D, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic sreening. N Engl J Med 2011;365:395-409.
2. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
4. Canadian Cancer Society's Annual Cancer Statistics. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, ON: Canadian Cancer Society, 2014. Accessed February 2014.
5. Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 2013;119:1381-1385.
6. Goulart BH, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw 2012;10:267-275.
7. Black C, Bagust A, Boland A, et al. The cinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess 2006;10:1-109.
8. Field J, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012;7:10-19.
9. Bach PB. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429.
10. Church T, Black WC, Aberle MD, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:1980-1991.
11. van Klaveren RJ. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-2229.
12. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103:1058-1068.
13. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-919.
14. Hinshaw LB, Jackson SA, Chen MY. Direct mailing was a successful recruitment strategy for a lung-cancer screening trial. J Clin Epidemiol 2007;60:853-857.
15. Aberle DR, DeMello S, Berg CD, et al National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920-931.
16. Kantarjian HM, Fojo T, Mathisen M, Zwelling LA. Cancer drugs in the United States: Justum Pretium - The just price. J Clin Oncol 2013;31:3600-3604.
17. The Patented Medicines Pricing Review Board public website. Compendium of policies, guidelines and procedures. Ottawa, Ontario: The Patented Medicines Pricing Review Board, 2012. Available at: http://www.pmprb-cepmb.gc.ca/english/view.asp?x=1733. Accessed December 2013.
18. Chirikos TN, Hazelton T, Tockman M, Clark R. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 2002;121:1507-1514.
19. Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One 2013;8:e71379.
20. Whynes DK. Could CT screening for lung cancer ever be cost effective in the United Kingdom? Cost Eff Resour Alloc 2008;6:5.
21. Wisnivesky JP, Mushlin AI, Sicherman N, Henschke C. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest 2003;124:614-621.
22. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers. JAMA 2003;289:313-322.
23. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-1848.
24. Cipriano LE, Romanus D, Earle CC, et al. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health 2011;14:41-52.
25. Canadian Institute for Health Information. End-of-Life Hospital Care for Cancer Patients. Available at: https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC2162&lang=en&media=0, 2013. Accessed March 2014.
26. A systematic review to update the US Preventative Services Task Force's recommendation for LDCT screening for lung cancer. Available at: http://www.uspreventiveservicestaskforce.org/uspstf13/lungcan/lungcanart.htm. Accessed October 2013.
27. Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer. Cancer 2009;115:5218-5227.
28. Statistics Canada public population and demographics data tables. Available at: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo62a-eng.htm. Accessed November, 2013.
29. Statistics Canada public population and demographics data tables. Available at: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo52a-eng.htm. Accessed November, 2013.
30. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-736.
31. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-254.